Literature DB >> 20517629

Recurrent respiratory papillomatosis: an overview.

Qingliang Xue1, Haitao Wang, Jianxin Wang.   

Abstract

Recurrent respiratory papillomatosis (RRP) primarily caused by human papillomas virus is a rare and benign neoplasm, primarily involving the epithelium mucosae of the respiratory tract. RRP may occur anywhere in the respiratory tract with a predilection to the laryngeal area and may potentially threaten life. Because of the absence of specific clinical manifestations, the diagnosis of this disease is easily delayed. The high awareness of RRP and performing endoscopy as soon as possible in suspected patients are the prerequisites for early diagnosis. Surgical removal on endoscope is still a fundamental treatment. Adjuvant treatment is required only in some patients. Because of the potential of malignant transformation and recurrence, careful follow-up for RRP is required for early detection and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20517629     DOI: 10.1007/s10096-010-0963-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

1.  The potential of human papillomavirus vaccines.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

2.  Recurrent respiratory papillomatosis in pregnancy: a case of emergent airway management.

Authors:  W Cooper Scurry; Johnathan D McGinn
Journal:  Ear Nose Throat J       Date:  2008-06-13       Impact factor: 1.697

3.  Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.

Authors:  Michael J Silverberg; Poul Thorsen; Henning Lindeberg; Linda A Grant; Keerti V Shah
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

4.  Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.

Authors:  P L Rady; V J Schnadig; R L Weiss; T K Hughes; S K Tyring
Journal:  Laryngoscope       Date:  1998-05       Impact factor: 3.325

5.  Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.

Authors:  Valentin Gerein; Eugen Rastorguev; Johann Gerein; Peter Jecker; Herbert Pfister
Journal:  Ann Otol Rhinol Laryngol       Date:  2005-06       Impact factor: 1.547

6.  Is cryotherapy treating or infecting?

Authors:  S N Tabrizi; S M Garland
Journal:  Med J Aust       Date:  1996-03-04       Impact factor: 7.738

7.  Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.

Authors:  Pierre Vandepapeliere; Renzo Barrasso; Chris J L M Meijer; Jan M M Walboomers; Martine Wettendorff; Lawrence R Stanberry; Charles J N Lacey
Journal:  J Infect Dis       Date:  2005-11-11       Impact factor: 5.226

8.  The cost of juvenile-onset recurrent respiratory papillomatosis.

Authors:  D Bishai; H Kashima; K Shah
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-08

9.  Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.

Authors:  J Scott McMurray; Nadine Connor; Charles N Ford
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-07       Impact factor: 1.547

10.  Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx.

Authors:  S O Ulualp; M W Ryan; S T Wright
Journal:  J Laryngol Otol       Date:  2007-04-10       Impact factor: 1.469

View more
  11 in total

1.  Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.

Authors:  M Grasso; M Remacle; V Bachy; S Van Der Vorst; G Lawson
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

2.  Juvenile recurrent respiratory papillomatosis: A rare masquerade of asthma.

Authors:  W H Boo; P Rajan; S M Ching; P Y Lee
Journal:  Malays Fam Physician       Date:  2015-08-31

3.  Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.

Authors:  Virgilijus Uloza; Vykintas Liutkevičius; Dalia Pangonytė; Viktoras Saferis; Vaiva Lesauskaitė
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-23       Impact factor: 2.503

4.  Squamous cell carcinoma in the larynx in a 7-year-child.

Authors:  Hong Kai Zhang; Hong Gang Liu
Journal:  Pediatr Surg Int       Date:  2011-05-18       Impact factor: 1.827

5.  Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.

Authors:  Irena Hočevar-Boltežar; Mojca Matičič; Maja Sereg-Bahar; Nina Gale; Mario Poljak; Boštjan Kocjan; Miha Zargi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-26       Impact factor: 2.503

6.  Suppression of respiratory papillomatosis with malignant transformation by erlotinib in a kidney transplant recipient.

Authors:  Zhonglin Hao; Thomas Dillard; Paul Biddinger; Vijay Patel
Journal:  BMJ Case Rep       Date:  2013-08-28

7.  Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review.

Authors:  Stamatis Katsenos; Heinrich D Becker
Journal:  Case Rep Oncol       Date:  2011-03-23

8.  Prevalence, clinical presentations, associated risk factors and recurrence of laryngeal papillomatosis among inpatients attended at a Tertiary Hospital in Northern zone Tanzania.

Authors:  Marco James; Denis Katundu; Desderius Chussi; Peter Shija
Journal:  Pan Afr Med J       Date:  2018-07-16

9.  Effects of conjugated linoleic acid and high oleic acid safflower oil in the treatment of children with HPV-induced laryngeal papillomatosis: a randomized, double-blinded and crossover preliminary study.

Authors:  Louise Louw
Journal:  Lipids Health Dis       Date:  2012-10-12       Impact factor: 3.876

Review 10.  Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.

Authors:  M Fusconi; M Grasso; A Greco; A Gallo; F Campo; M Remacle; R Turchetta; G Pagliuca; M DE Vincentiis
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-12       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.